GPT-4 Fails On Real Healthcare Tasks: New HealthBench Test Reveals The Gaps
By: mpost io|2025/05/14 22:45:05
0
Share
Large language models are everywhere — from search to coding and even patient-facing health tools. New systems are being introduced almost weekly, including tools that promise to automate clinical workflows. But can they actually be trusted to make real medical decisions? A new benchmark, called HealthBench, says not yet. According to the results, models like GPT-4 (from OpenAI) and Med-PaLM 2 (from Google DeepMind) still fall short on practical healthcare tasks, especially when accuracy and safety matter most.HealthBench is different from older tests. Instead of using narrow quizzes or academic question sets, it challenges AI models with real-world tasks. These include picking treatments, making diagnoses, and deciding what steps a doctor should take next. That makes the results more relevant to how AI might actually be used in hospitals and clinics.Across all tasks, GPT-4 performed better than previous models. But the margin was not enough to justify real-world deployment. In some cases, GPT-4 chose incorrect treatments. In others, it offered advice that could delay care or even increase harm. The benchmark makes one thing clear: AI might sound smart, but in medicine, that’s not good enough.Real Tasks, Real Failures: Where AI Still Breaks in MedicineOne of HealthBench’s biggest contributions is how it tests models. It includes 14 real-world healthcare tasks across five categories: treatment planning, diagnosis, care coordination, medication management, and patient communication. These aren’t made-up questions. They come from clinical guidelines, open datasets, and expert-authored resources that reflect how actual healthcare works.On many tasks, large language models showed consistent errors. For instance, GPT-4 often failed at clinical decision-making, such as determining when to prescribe antibiotics. In some examples, it was overprescribed. In others, it missed important symptoms. These types of mistakes are not just wrong — they could cause real harm if used in actual patient care.The models also struggled with complex clinical workflows. For example, when asked to recommend follow-up steps after lab results, GPT-4 gave generic or incomplete advice. It often skipped context, didn’t prioritize urgency, or lacked clinical depth. That makes it dangerous in cases where time and order of operations are critical.In medication-related tasks, accuracy dropped further. The models frequently mixed up drug interactions or gave outdated guidance. That’s especially alarming since medication errors are already one of the top causes of preventable harm in healthcare.Even when the models sounded confident, they weren’t always right. The benchmark revealed that fluency and tone didn’t match clinical correctness. This is one of the biggest risks of AI in health — it can “sound” human while being factually wrong.Why HealthBench Matters: Real Evaluation for Real ImpactUntil now, many AI health evaluations used academic question sets like MedQA or USMLE-style exams. These benchmarks helped measure knowledge but didn’t test whether models could think like doctors. HealthBench changes that by simulating what happens in actual care delivery.Instead of one-off questions, HealthBench looks at the entire decision chain — from reading a symptom list to recommending care steps. That gives a more complete picture of what AI can or can’t do. For instance, it tests if a model can manage diabetes across multiple visits or track lab trends over time.The benchmark also grades models on multiple criteria, not just accuracy. It checks for clinical relevance, safety, and the potential to cause harm. That means it’s not enough to get a question technically right — the answer also has to be safe and useful in real-life settings.Another strength of HealthBench is transparency. The team behind it released all prompts, scoring rubrics, and annotations. That allows other researchers to test new models, improve evaluations, and build on the work. It’s an open call to the AI community: if you want to claim your model is useful in healthcare, prove it here.GPT-4 and Med-PaLM 2 Still Not Ready for ClinicsDespite recent hype around GPT-4 and other large models, the benchmark shows they still make serious medical mistakes. In total, GPT-4 only achieved around 60–65% correctness on average across all tasks. In high-stakes areas like treatment and medication decisions, the score was even lower.Med-PaLM 2, a model tuned for healthcare tasks, didn’t perform much better. It showed slightly stronger accuracy in basic medical recall but failed at multi-step clinical reasoning. In several scenarios, it offered advice that no licensed physician would support. These include misidentifying red-flag symptoms and suggesting non-standard treatments.The report also highlights a hidden danger: overconfidence. Models like GPT-4 often deliver wrong answers in a confident, fluent tone. That makes it hard for users — even trained professionals — to detect errors. This mismatch between linguistic polish and medical precision is one of the key risks of deploying AI in healthcare without strict safeguards.To put it plainly: sounding smart isn’t the same as being safe.What Needs to Change Before AI Can Be Trusted in HealthcareThe HealthBench results aren’t just a warning. They also point to what AI needs to improve. First, models must be trained and evaluated using real-world clinical workflows, not just textbooks or exams. That means including doctors in the loop — not just as users, but as designers, testers, and reviewers.Second, AI systems should be built to ask for help when uncertain. Right now, models often guess instead of saying, “I don’t know.” That’s unacceptable in healthcare. A wrong answer can delay diagnosis, increase risk, or break patient trust. Future systems must learn to flag uncertainty and refer complex cases to humans.Third, evaluations like HealthBench must become the standard before real deployment. Just passing an academic test is no longer enough. Models must prove they can handle real decisions safely, or they should stay out of clinical settings entirely.The Path Ahead: Responsible Use, Not HypeHealthBench doesn’t say that AI has no future in healthcare. Instead, it shows where we are today — and how far there is still to go. Large language models can help with administrative tasks, summarization, or patient communication. But for now, they are not ready to replace or even reliably support doctors in clinical care.Responsible use means clear limits. It means transparency in evaluation, partnerships with medical professionals, and constant testing against real medical tasks. Without that, the risks are too high.The creators of HealthBench invite the AI and healthcare community to adopt it as a new standard. If done right, it could push the field forward — from hype to real, safe impact.The post GPT-4 Fails On Real Healthcare Tasks: New HealthBench Test Reveals The Gaps appeared first on Metaverse Post.
You may also like

The large models in the United States are moving towards closure in the name of security
The government successfully inserted itself as an approver between commercial AI models and their users for the first time.

Morning Report | CoinEx becomes a key hub for Iran to evade sanctions, involving over $3.8 billion in funds; Kalshi seeks a new round of financing, with a valuation potentially rising to $40 billion
Overview of Important Market Events on June 25

From the white-haired stock god to the billionaire fund mogul, the smart people shorting Nvidia are all getting rich using the same framework
Give up on heavily investing in Nvidia's "nine major bottlenecks"! This article analyzes the underlying logic behind top AI investors making billions: physical infrastructure such as electricity, HBM, and optical interconnects are the true keys to wealth in AI hardware.

Why do cryptocurrency projects always like to change their names?
In many cases, the old names of encryption projects have no competitive advantage, only historical baggage.

Global Launch: As predictions become the most scarce asset in the AI era, Manadia is defining the next generation of the value internet
The trusted AI prediction ecosystem Manadia, which has secured $7 million in funding from well-known institutions like OKX, will globally launch in June. The core token UMXM has already been listed on multiple mainstream platforms, inviting you to seize the new blue ocean of the trillion-level predi...

Who is footing the bill for the $64 billion accounting frenzy?
Affected by Bitcoin falling below $60,000, publicly listed companies heavily invested in this asset are facing huge paper losses and valuation discounts, and their debt structure and accounting standards may trigger structural liquidity risks in the future.

I never expected that the first application of AI x Crypto would be in security auditing
AI has accelerated attack efficiency and also promoted the upgrade of defense systems. The security audit sector is undergoing a transition from a dividend model to a competitive model.

What is your view on Binance's competitive advantages?
When the dividends of rule arbitrage gradually approach zero, can we produce product strength, governance capability, and trust that are commensurate with its scale?

ETH has entered a non-consensus phase, and the turning point is approaching!
This has nothing to do with the Ethereum Foundation or Ethlabs; Ethereum needs to win by solving real problems.

The shift in the cloud of the air: from despising stablecoins a year ago to the high-profile entry of capital today
It can continue to question the cost-effectiveness of stablecoins in the G10 currency corridor, but it cannot ignore the structural opportunities of stablecoins in emerging markets, corporate finance, and on-chain settlements.

The survival dilemma of small and medium exchanges behind the withdrawal anomalies exposed by AscendEX
The living space is constantly being compressed.

Why Is Bitcoin Falling Below $60K? 5 Key Market Drivers Explained
Bitcoin has dropped sharply amid ETF outflows, Strategy stock weakness, AI stock rallies, and changing Fed expectations. Explore the key forces driving BTC’s latest correction and what traders should watch next.

Bitcoin vs. Gold in 2026: Which Asset Performs Better in Different Markets?
Bitcoin vs. gold in 2026: Why are both assets falling, and what does their changing correlation mean? Discover what drives Bitcoin and gold prices and how traders can navigate different market conditions.

Morning News | The draft amendment to the People's Bank of China Law aims to clarify the legal status of digital renminbi; South Korea will transfer about 40 unregistered virtual asset service providers to law enforcement agencies
Overview of Important Market Events on June 24

The cryptocurrency industry has entered the "Show Me" era: merely relying on vision is no longer enough
The awareness level of the audience in the cryptocurrency industry—including media, institutions, and retail investors—is steadily increasing, and this trend has become a foregone conclusion.

Interpreting the Ethereum Foundation's new structure: Reaffirming self-sovereignty amid institutional trends
The Ethereum Foundation has announced a new five-layer working framework, clarifying the focus of future development and reaffirming its commitment to decentralized core values amidst the wave of institutionalization.

Former SpaceX engineer reconstructs the financial execution system using first principles
Plan Execution Lab completes angel round financing for Singapore family office, with a valuation of 50 million USD.

Standard Chartered Bank sings a 50x rhapsody again, aiming for AAVE to reach 3500 USD
The throne of DeFi lending still exists, but the foundation beneath the throne needs to undergo a reconstruction or reinforcement.
The large models in the United States are moving towards closure in the name of security
The government successfully inserted itself as an approver between commercial AI models and their users for the first time.
Morning Report | CoinEx becomes a key hub for Iran to evade sanctions, involving over $3.8 billion in funds; Kalshi seeks a new round of financing, with a valuation potentially rising to $40 billion
Overview of Important Market Events on June 25
From the white-haired stock god to the billionaire fund mogul, the smart people shorting Nvidia are all getting rich using the same framework
Give up on heavily investing in Nvidia's "nine major bottlenecks"! This article analyzes the underlying logic behind top AI investors making billions: physical infrastructure such as electricity, HBM, and optical interconnects are the true keys to wealth in AI hardware.
Why do cryptocurrency projects always like to change their names?
In many cases, the old names of encryption projects have no competitive advantage, only historical baggage.
Global Launch: As predictions become the most scarce asset in the AI era, Manadia is defining the next generation of the value internet
The trusted AI prediction ecosystem Manadia, which has secured $7 million in funding from well-known institutions like OKX, will globally launch in June. The core token UMXM has already been listed on multiple mainstream platforms, inviting you to seize the new blue ocean of the trillion-level predi...
Who is footing the bill for the $64 billion accounting frenzy?
Affected by Bitcoin falling below $60,000, publicly listed companies heavily invested in this asset are facing huge paper losses and valuation discounts, and their debt structure and accounting standards may trigger structural liquidity risks in the future.
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Program:support@weex.com





